The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS

Byeong-Sun Choi1, Yong-Keun Park, Joo-Shil Lee

  • 1Centre for AIDS Research, Department of Virology, National Institute of Health, Seoul, Korea.

Insights

Changes in CD28 and HLA-DR molecules on T cells during HIV infection reveal distinct patterns. CD4+ T cell molecule expression changes predict disease progression, unlike CD8+ T cells.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • HIV infection significantly impacts T cell populations, crucial for immune response.
  • CD28 and HLA-DR are key molecules on T cells involved in immune regulation and activation.
  • Understanding T cell marker dynamics is vital for monitoring HIV disease progression.

Purpose of the Study:

  • To investigate the expression patterns of CD28 and HLA-DR on CD4+ and CD8+ T cells in HIV-infected individuals.
  • To correlate these molecular changes with CD4+ T cell counts and disease stages.
  • To assess the predictive value of these markers for HIV disease progression.

Main Methods:

  • Categorization of 130 HIV-infected Koreans into four groups based on CD4+ T cell counts.
  • Flow cytometry analysis to quantify CD28 and HLA-DR expression on CD4+ and CD8+ T cells.
  • Statistical analysis to compare marker expression across different disease stages.

Main Results:

  • CD4+ T cells showed decreased CD28 and increased HLA-DR expression correlating with lower CD4+ counts.
  • CD8+ T cells exhibited rapid CD28 down-regulation early in HIV infection, with stable expression thereafter.
  • The combined expression of CD28 and HLA-DR on both T cell types remained relatively constant (~100% and ~55-60%).

Conclusions:

  • CD4+ T cell CD28/HLA-DR expression changes are more indicative of HIV disease progression than those on CD8+ T cells.
  • CD8+ T cell CD28 down-regulation, despite severity, may not impact survival in this cohort.
  • Further research is needed to elucidate the constant sum of CD28 and HLA-DR expression in T cells.